Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
NCT00280436
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
122
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Initiation and Maintenance Disorders
Insomnia
Interventions
DRUG:
GW679769
Sponsor
GlaxoSmithKline